Replies to post #113759 on Anavex Life Sciences Corp (AVXL)

[Amatuer17]

"Azeliragon Merely Slows Alzheimer’s Decline, Anavex Stops It "

Show me where it is proven that Anavex stops ALZ

Heck it is not even shown conclusively that it slows Alz.

So do nit make unproven claim that even company is not making.

[Investor2014]

Slowing the progression of decline in Alzheimer's better than current SOC should be enough to replace it. If Azeliragon does that, then likely vTv will be making potentially significant revenue before Anavex.

From all we know about the science, Falconer, I agree that Anavex is the better bet. If so Anavex may then replace SOC, and if SOC is Azeliragon at the time replace them.

Only more time will tell...

[OFP]

Azeliragon Merely Slows Alzheimer’s Decline, Anavex Stops It

Blatantly false. Review the 1 year data and look at the declines of the only 2 measures of value...MMSE and ADLs. Missling's claim that 2-73 "stabilizes" AD is dubious enough. Claiming it stops AD is indefensible.

A glaring advantage of Azeliragon is that it has a differentiated MOA, 2-73 does NOT as far as anyone knows.


(Apologies to Amateur17 who, I now see, pretty much wrote the same thing before me)

[frrol]

There are several things wrong with this post. I'll point out just one since I'm sure others are correcting you as well: 2-73 is not the "only S1 agonist", let alone the only one used with AD patients. If you did not know this, you need more DD. It is always important to be factual and objective. No excuses, and you know better Falconer.

[frrol]

Two things factually incorrect in your post. Again.